News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
568,200 Results
Type
Article (47263)
Company Profile (119)
Press Release (520806)
Multimedia
Podcasts (153)
Webinars (22)
Section
Business (149005)
Career Advice (2427)
Deals (28651)
Drug Delivery (152)
Drug Development (70416)
Employer Resources (159)
FDA (16218)
Job Trends (12259)
News (271575)
Policy (30328)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2365)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (154)
Alliances (36964)
ALS (188)
Alzheimer's disease (1786)
Antibody-drug conjugate (ADC) (377)
Approvals (16413)
Artificial intelligence (575)
Autoimmune disease (225)
Automation (40)
Bankruptcy (319)
Best Places to Work (9343)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (72)
Bladder cancer (180)
Brain cancer (61)
Breast cancer (639)
Cancer (5111)
Cardiovascular disease (460)
Career advice (2058)
Career pathing (43)
CAR-T (277)
CDC (71)
Celiac Disease (1)
Cell therapy (786)
Cervical cancer (41)
Clinical research (61059)
Collaboration (1696)
Company closure (6)
Compensation (1271)
Complete response letters (90)
COVID-19 (2750)
CRISPR (96)
C-suite (912)
Cystic fibrosis (147)
Data (6690)
Decentralized trials (3)
Denatured (33)
Depression (169)
Dermatology (57)
Diabetes (526)
Diagnostics (5742)
Digital health (44)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (267)
Drug pricing (232)
Drug shortages (33)
Duchenne muscular dystrophy (276)
Earnings (63969)
Editorial (71)
Employer branding (20)
Employer resources (142)
Events (84905)
Executive appointments (952)
FDA (19606)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1403)
Gene editing (210)
Generative AI (53)
Gene therapy (672)
GLP-1 (1128)
Government (4288)
Grass and pollen (8)
Guidances (387)
Healthcare (15228)
HIV (74)
Huntington's disease (56)
IgA nephropathy (94)
Immunology and inflammation (315)
Immuno-oncology (85)
Indications (145)
Infectious disease (3053)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (117)
Intellectual property (259)
Interviews (454)
IPO (14321)
IRA (58)
Job creations (3215)
Job search strategy (1676)
JPM (69)
Kidney cancer (19)
Labor market (91)
Layoffs (626)
Leadership (44)
Legal (7149)
Liver cancer (99)
Longevity (23)
Lung cancer (686)
Lymphoma (391)
Machine learning (48)
Management (52)
Manufacturing (869)
MASH (184)
Medical device (11795)
Medtech (11861)
Mergers & acquisitions (15399)
Metabolic disorders (1468)
mRNA (201)
Multiple sclerosis (158)
NASH (23)
Neurodegenerative disease (394)
Neuropsychiatric disorders (110)
Neuroscience (3164)
Neurotech (2)
NextGen: Class of 2026 (5123)
Non-profit (3309)
Now hiring (33)
Obesity (737)
Opinion (294)
Ovarian cancer (169)
Pain (218)
Pancreatic cancer (250)
Parkinson's disease (337)
Partnered (28)
Patents (531)
Patient recruitment (562)
Peanut (57)
People (45855)
Pharmaceutical (35)
Pharmacy benefit managers (34)
Phase 1 (18359)
Phase 2 (26447)
Phase 3 (21484)
Pipeline (6803)
Policy (359)
Postmarket research (2315)
Preclinical (7419)
Press Release (29)
Prostate cancer (277)
Psychedelics (58)
Radiopharmaceuticals (272)
Rare diseases (1046)
Real estate (4400)
Recruiting (65)
Regulatory (23918)
Reports (43)
Research institute (2169)
Resumes & cover letters (406)
Rett syndrome (32)
RNA editing (17)
RSV (82)
Schizophrenia (169)
Series A (242)
Series B (183)
Service/supplier (9)
Sickle cell disease (106)
Special edition (27)
Spinal muscular atrophy (147)
Sponsored (50)
Startups (2861)
State (1)
Stomach cancer (21)
Supply chain (117)
Tariffs (102)
The Weekly (118)
Vaccines (1149)
Venture capital (106)
Weight loss (515)
Women's health (93)
Worklife (23)
Date
Last 7 days (588)
Last 30 days (2322)
Last 365 days (28456)
2026 (7573)
2025 (28721)
2024 (31796)
2023 (35489)
2022 (45737)
2021 (49137)
2020 (46186)
2019 (36968)
2018 (28041)
2017 (28312)
2016 (26325)
2015 (28763)
2014 (22391)
2013 (18240)
2012 (19483)
2011 (19938)
2010 (18065)
Location
Africa (695)
Alabama (73)
Alaska (6)
Arizona (254)
Arkansas (11)
Asia (33553)
Australia (5774)
California (11380)
Canada (2779)
China (1106)
Colorado (448)
Connecticut (501)
Delaware (330)
Europe (81261)
Florida (1743)
Georgia (355)
Hawaii (4)
Idaho (42)
Illinois (841)
India (65)
Indiana (464)
Iowa (22)
Japan (464)
Kansas (109)
Kentucky (33)
Louisiana (31)
Maine (74)
Maryland (1393)
Massachusetts (8269)
Michigan (286)
Minnesota (598)
Mississippi (5)
Missouri (138)
Montana (14)
Nebraska (23)
Nevada (124)
New Hampshire (67)
New Jersey (3090)
New Mexico (16)
New York (2979)
North Carolina (1456)
North Dakota (7)
Northern California (5711)
Ohio (311)
Oklahoma (18)
Oregon (34)
Pennsylvania (2209)
Puerto Rico (20)
Rhode Island (34)
South America (1053)
South Carolina (73)
South Dakota (1)
Southern California (4470)
Tennessee (170)
Texas (1741)
United States (39942)
Utah (287)
Vermont (1)
Virginia (271)
Washington D.C. (73)
Washington State (891)
West Virginia (4)
Wisconsin (118)
Wyoming (1)
568,200 Results for "panlab s l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anaergia S.r.l. Expands Scope at Three Biomethane Facilities Being Built for QGM S.á.r.l. in Italy, Increasing Contracts by C$17 Million
March 17, 2026
·
3 min read
Press Releases
Disclosure of a transparency notification from AOC Pharma S.à r.l.
March 1, 2026
·
2 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
L7 Informatics CEO explains why the next wave of life sciences innovation depends on digital unified platforms that orchestrate workflows, contextualize data, and enable AI-actionable operations.
February 12, 2026
·
1 min read
Press Releases
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.
January 7, 2026
·
5 min read
Press Releases
Convergent Therapeutics Appoints Elizabeth L. Montgomery Chief People Officer
January 29, 2026
·
2 min read
Press Releases
Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC
March 24, 2026
·
3 min read
Press Releases
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
November 19, 2025
·
7 min read
Press Releases
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
March 27, 2026
·
3 min read
Press Releases
Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC
January 12, 2026
·
10 min read
Press Releases
ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors
March 12, 2026
·
7 min read
1 of 56,820
Next
